A Feasibility Study for the Use of Multispectral Optoacoustic Tomography in the Detection of Tumors

NCT04365413 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2023-12-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and potential of a new experimental imaging instrument called multispectral optoacoustic tomography (MSOT) to detect tumors and lymph nodes with tumors.

Conditions

Interventions

DEVICE

MSOT Device

The MSOT Device will be used to take images of the tumor and/or lymph nodes of patients with solid tumors before and after surgery to measure the margins of the tumor and/or positive lymph node.

PROCEDURE

Temperature Measurement

The temperature of the skin will be measured prior to and after MSOT imaging.

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Lacey McNally, PhD · University of Oklahoma

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-22
Primary Completion
2021-07-12
Completion
2022-12-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04365413 on ClinicalTrials.gov